Elyxium Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$573K Buy
1,166
+108
+10% +$58.6K 0.18% 96
2025
Q4
$613K Buy
1,058
+20
+2% +$11.3K 0.17% 95
2025
Q3
$503K Buy
1,038
+5
+0.5% +$2.33K 0.18% 98
2025
Q2
$419K Sell
1,033
-75
-7% -$31.4K 0.16% 112
2025
Q1
$551K Buy
+1,108
New +$600K 0.24% 83
2024
Q4
Sell
-1,048
Closed -$648K 127
2024
Q3
$648K Buy
+1,048
New +$620K 0.36% 58

Other funds holding TMO

Elyxium Wealth's TMO Position: Q1 2026 in Review

Elyxium Wealth increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $58.6K and bringing the position to 1,166 shares worth $573K. The position accounts for 0.18% of the portfolio, ranked #96.

Elyxium Wealth first reported a position in TMO in Q3 2024 and has held it in 6 quarters since. The position peaked at $648K in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Elyxium Wealth held 1,166 shares of Thermo Fisher Scientific worth $573K as of Q1 2026.
  • Elyxium Wealth bought 108 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.6K.
  • Thermo Fisher Scientific made up 0.18% of Elyxium Wealth's portfolio in Q1 2026, its #96 holding.
  • Elyxium Wealth first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 6 quarters since.
  • Elyxium Wealth's Thermo Fisher Scientific position peaked at $648K in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.